corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 7646

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Fridman GA, Zimerman CA, Bregni C.
Consumption of antidepressant and anxiolytic drugs in Argentina in 1998
Ars Pharmaceutica 2003; 43:(1-3):5-12


Abstract:

Background: The aim of this study is to carry out a statistical analysis on the consumption of antidepressant and anxiolytic drugs during the year 1998, in order to draw conclusions that will facilitate the rational use of these medicines. Methods: Distribution data was obtained from two of the biggest drug suppliers in the North-eastern region of Argentina, as well as from community pharmacies involved in the production of pharmacist prescriptions of these drugs. Results: The information obtained was as follows: Quantity of units of medicine distributed: 18,080 of anti-depressants and 177,205 of anxiolytic drugs. The number of community pharmqcy prescriptions containing these drugs was 4440. Conclusions: Although pharmacist preparations are more rationally formulated in community pharmacies, the pharmaceutical industry predominates in the production of these medicines. Such a finding is a cause for concern.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.